Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005479 · ClinicalTrials.gov registry record
Diabetes, Lipoproteins and Accelerated Vascular Disease
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 164
- Enrollment target
NCT00005479: Completed study, sponsored by Columbia University.
NCT00005479 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 164 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005479 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
Study Summary
To better understand the excess cardiovascular disease associated with diabetes mellitus.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 1996-09 |
| Est. Completion | 2009-09 |
What the finished NCT00005479 record still lists
NCT00005479 is an observational study that tracks outcomes without assigning an intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00005479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005479 about?
NCT00005479 is a clinical study titled "Diabetes, Lipoproteins and Accelerated Vascular Disease". To better understand the excess cardiovascular disease associated with diabetes mellitus.
What is the current status of trial NCT00005479?
This trial is currently completed. The enrollment target is 164 participants. The study started on 1996-09. Estimated completion is 2009-09.
Who is sponsoring clinical trial NCT00005479?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia